Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01048281 · ClinicalTrials.gov registry record

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

A clinical trial of Esophageal Cancer and Stomach Cancer, sponsored by Stanford University.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT01048281: Recruiting study of Esophageal Cancer and Stomach Cancer, sponsored by Stanford University.

NCT01048281 is a study of Esophageal Cancer and Stomach Cancer that is actively recruiting participants, run by Stanford University. The registered enrollment target is 100 participants, below the 498-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01048281, a study of Esophageal Cancer and Stomach Cancer, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.

Conditions Studied

Esophageal Cancer Stomach Cancer Gastrointestinal Stromal Tumor (GIST) Gastric (Stomach) Cancer Gastro-Esophageal(GE) Junction Cancer

Interventions

  • PROCEDURE Blood draw
  • PROCEDURE Tissue tumor biopsy

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2002-08
Est. Completion 2099-01
Stanford University

1,744 total trials

What NCT01048281 shows while recruiting

NCT01048281 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 498-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (80% lower).

The record links to 5 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Blood draw is the first listed.

NCT01048281 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01048281 about?

NCT01048281 is a clinical study titled "Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma". Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn ...

What is the current status of trial NCT01048281?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2002-08. Estimated completion is 2099-01.

What conditions does trial NCT01048281 study?

This clinical trial studies the following conditions: Esophageal Cancer, Stomach Cancer, Gastrointestinal Stromal Tumor (GIST), Gastric (Stomach) Cancer, Gastro-Esophageal(GE) Junction Cancer.

What interventions are being tested in trial NCT01048281?

The interventions under investigation include: Blood draw (PROCEDURE), Tissue tumor biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT01048281?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01048281 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Esophageal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01048281's enrollment target sits among peer trials

100 51st of 123 higher than 69 of 123 other Esophageal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Esophageal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

  • NCT01773278 · 100 participants · Phase 2

    Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

More recruiting context for NCT01048281

Source: ClinicalTrials.gov NCT01048281, the US trial registry maintained by the National Library of Medicine. NCT01048281 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.